RecruitingNot ApplicableNCT04626050

General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19

A Brief Phased Two-Step Intervention for Treating General Psychological Distress, PTSD and Co-Morbidities in Healthcare Workers Consequent to the COVID-19 Pandemic


Sponsor

Weill Medical College of Cornell University

Enrollment

120 participants

Start Date

Jan 20, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

It is expected that large numbers of healthcare workers will experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. The purpose of this study is to find interventions which are helpful in treating psychological distress in healthcare workers caring for COVID-19 patients. There are two phases of the study. All participants will take part in Phase I, which consists of 4 sessions over a two-week period of either a narrative writing intervention or a medical music intervention. Participants will be randomly assigned to the narrative writing intervention or medical music intervention. After Phase I, participants will be re-assessed. Healthcare workers who meet criteria for PTSD will be given the option to participate in Phase II of the study, in which they will be offered a choice between one of two evidence-based treatments for PTSD: Interpersonal Therapy (IPT) or Exposure Therapy (ET). Both treatments are comprised of ten 75-minute sessions scheduled twice weekly. Participants will be allowed to choose a preferred treatment in Phase II. After Phase II participants will complete a final assessment concluding the study. All interventions will be offered using distance technology.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the mental health impacts of the COVID-19 pandemic on healthcare workers — including anxiety, depression, PTSD (post-traumatic stress disorder), and other conditions. A second phase of the study will offer a treatment for those diagnosed with PTSD. **You may be eligible if...** - You are a healthcare worker who provided care or support to COVID-19 patients - You are over 18 years old - You speak and understand English - You are medically stable - If you take psychiatric medication, your dose has been stable for at least 60 days - For Phase II: you have a current PTSD diagnosis **You may NOT be eligible if...** - You have a serious unstable medical condition that prevents regular participation - You are considered a safety risk (homicidal, suicidal, or similar) - You have been diagnosed with schizophrenia or another psychotic disorder - You are currently in another clinical trial or evidence-based PTSD treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMedical Music

Participants randomized to this condition will complete 4 medical music sessions over the course of 2 weeks

BEHAVIORALNarrative Writing

Participants randomized to this condition will complete 4 narrative writing sessions over the course of 2 weeks

BEHAVIORALProlonged Exposure Therapy

Psychotherapy including imaginal exposure for PTSD

BEHAVIORALInterpersonal Psychotherapy

Psychotherapy that focuses on the effects of PTSD on current interpersonal functioning


Locations(1)

Weill Cornell Medicine

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04626050


Related Trials